Literature DB >> 30606274

Against the stream: early diagnosis of dementia, is it so desirable?

Carol Brayne1, Sarah Kelly1.   

Abstract

SummaryThe Prime Minister's challenge on dementia called for improved dementia diagnosis rates, based on assumptions of benefit to individuals and those who care for them. Subsequent policies have led to increased target drives for clinical practice to achieve early diagnosis of dementia through intense case identification. However, the current evidence base and treatment options do not support screening for dementia, and there is little empirical evidence that such intensive case identification and early diagnosis for dementia is justified without a better understanding of the benefits, costs and potential harms to individuals and services.Declaration of interestNone.

Entities:  

Keywords:  Dementia; diagnosis; early diagnosis; screening

Year:  2019        PMID: 30606274     DOI: 10.1192/bjb.2018.107

Source DB:  PubMed          Journal:  BJPsych Bull        ISSN: 2056-4694


  4 in total

1.  Automated detection of patients with dementia whose symptoms have been identified in primary care but have no formal diagnosis: a retrospective case-control study using electronic primary care records.

Authors:  Elizabeth Ford; Joanne Sheppard; Seb Oliver; Philip Rooney; Sube Banerjee; Jackie A Cassell
Journal:  BMJ Open       Date:  2021-01-22       Impact factor: 2.692

2.  Informal dementia care: The carer's lived experience at the divides between policy and practice.

Authors:  Anthony Britton; Martina Zimmermann
Journal:  Dementia (London)       Date:  2022-07-15

3.  Ageing and dementia: age-period-cohort effects of policy intervention in England, 2006-2016.

Authors:  Kamila Kolpashnikova
Journal:  BMC Geriatr       Date:  2021-06-26       Impact factor: 3.921

4.  Effect of neurological screening on early dementia detection in southern Italy.

Authors:  Maria Cristina De Cola; Giuseppe Triglia; Martina Camera; Francesco Corallo; Marcella Di Cara; Placido Bramanti; Viviana Lo Buono
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.